The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.

Richard A MalthanerEdward YuMichael SanataniDebra LewisAndrew WarnerA Rashid DarBrian P YaremkoJoel BiererDavid A PalmaDalilah FortinRichard I InculetEric FréchetteJacques RaphaelStewart GaedeSara KuruvillaJawaid YounusMark D VincentGeorge B Rodrigues

Published in: Thoracic cancer (2022)

Trimodality therapy is challenging for patients with resectable esophageal cancer regardless of whether it is given before or after surgery. Newer and less toxic protocols are needed.

Keyphrases

phase iii
phase ii
open label
clinical trial
study protocol
locally advanced
double blind
placebo controlled
rectal cancer
lymph node
randomized controlled trial
squamous cell carcinoma
radiation therapy
liver metastases
replacement therapy
muscle invasive bladder cancer